Literature DB >> 15146199

Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor.

Dal-Hee Min1, Wei-Jen Tang, Milan Mrksich.   

Abstract

Mass spectrometry (MS) analysis is applicable to a broad range of biological analytes and has the important advantage that it does not require analytes to be labeled. A drawback of MS methods, however, is the need for chromatographic steps to prepare the analyte, precluding MS from being used in chemical screening and rapid analysis. Here, we report that surfaces that are chemically tailored for characterization by matrix-assisted laser-desorption ionization time-of-flight MS eliminate the need for sample processing and make this technique adaptable to parallel screening experiments. The tailored substrates are based on self-assembled monolayers that present ligands that interact with target proteins and enzymes. We apply this method to screen a chemical library against protease activity of anthrax lethal factor, and report a compound that inhibits lethal factor activity with a K(i) of 1.1 microM and blocks the cleavage of MEK1 in 293 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15146199     DOI: 10.1038/nbt973

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  38 in total

1.  MALDI-TOF MS as a label-free approach to rapid inhibitor screening.

Authors:  Kenneth D Greis; Songtao Zhou; Thomas M Burt; Andrew N Carr; Elizabeth Dolan; Vijayasurian Easwaran; Artem Evdokimov; Richard Kawamoto; Jeff Roesgen; Gregory F Davis
Journal:  J Am Soc Mass Spectrom       Date:  2006-04-17       Impact factor: 3.109

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  Cellular Assays with a Molecular Endpoint Measured by SAMDI Mass Spectrometry.

Authors:  Eric J Berns; Maria D Cabezas; Milan Mrksich
Journal:  Small       Date:  2016-05-30       Impact factor: 13.281

4.  A novel pharmacophore model for the design of anthrax lethal factor inhibitors.

Authors:  Hongbin Yuan; Sherida L Johnson; Li-Hsing Chen; Jun Wei; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2010-06-21       Impact factor: 2.817

5.  Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.

Authors:  Ludovic Bannwarth; Allison B Goldberg; Catherine Chen; Benjamin E Turk
Journal:  Chem Biol       Date:  2012-07-27

6.  Highly predictive support vector machine (SVM) models for anthrax toxin lethal factor (LF) inhibitors.

Authors:  Xia Zhang; Elizabeth Ambrose Amin
Journal:  J Mol Graph Model       Date:  2015-11-17       Impact factor: 2.518

7.  Small molecule inhibitors of anthrax lethal factor toxin.

Authors:  John D Williams; Atiyya R Khan; Steven C Cardinale; Michelle M Butler; Terry L Bowlin; Norton P Peet
Journal:  Bioorg Med Chem       Date:  2013-11-13       Impact factor: 3.641

8.  Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.

Authors:  Sherida L Johnson; Li-Hsing Chen; Elisa Barile; Aras Emdadi; Mojgan Sabet; Hongbin Yuan; Jun Wei; Donald Guiney; Maurizio Pellecchia
Journal:  Bioorg Med Chem       Date:  2009-03-26       Impact factor: 3.641

9.  Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening.

Authors:  Ting-Lan Chiu; Jonathan Solberg; Satish Patil; Todd W Geders; Xia Zhang; Subhashree Rangarajan; Rawle Francis; Barry C Finzel; Michael A Walters; Derek J Hook; Elizabeth A Amin
Journal:  J Chem Inf Model       Date:  2009-12       Impact factor: 4.956

10.  Profiling the selectivity of DNA ligases in an array format with mass spectrometry.

Authors:  Joohoon Kim; Milan Mrksich
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.